Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126212261 | 12621226 | 1 | I | 20160720 | 20160729 | 20160804 | 20160804 | EXP | US-AMGEN-USASL2016099153 | AMGEN | 68.00 | YR | E | M | Y | 0.00000 | 20160804 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126212261 | 12621226 | 1 | PS | NEULASTA | PEGFILGRASTIM | 1 | Unknown | UNK | 125031 | SOLUTION FOR INJECTION | |||||||||
126212261 | 12621226 | 2 | SS | NEULASTA | PEGFILGRASTIM | 1 | 125031 | SOLUTION FOR INJECTION | |||||||||||
126212261 | 12621226 | 3 | SS | NEULASTA | PEGFILGRASTIM | 1 | 125031 | SOLUTION FOR INJECTION |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126212261 | 12621226 | 1 | Connective tissue neoplasm |
126212261 | 12621226 | 2 | Soft tissue neoplasm |
126212261 | 12621226 | 3 | Neutropenia |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126212261 | 12621226 | OT |
126212261 | 12621226 | DE |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126212261 | 12621226 | Death |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |